Literature DB >> 10820486

The role of wild-type and mutated N-ras in the malignant transformation of liver cells.

C Schleger1, R Heck, P Steinberg.   

Abstract

In order to determine the role of N-ras overexpression and mutation in malignant liver cell transformation, wild-type and mutated N-ras were transfected into the rat liver epithelial cell line OC/CDE 22, and N-ras expression, growth kinetics, growth in soft agar, and tumorigenicity in vivo as well as the involvement of the mitogen-activated protein kinase (MAPK) signal transduction pathway in the expression of the malignant phenotype were analyzed. Although OC/CDE 22 cells transfected with wild-type N-ras showed a high expression of N-ras at the mRNA and protein levels, the cells did not grow in soft agar and were not tumorigenic in vivo. In contrast, OC/CDE 22 cells transfected with mutated N-ras showed anchorage-independent growth and were tumorigenic. When cultured in fetal bovine serum-supplemented medium, OC/CDE 22 cells expressing mutant N-ras showed a higher proliferation rate than nontransfected OC/CDE 22 cells or OC/CDE 22 cells transfected with wild-type N-ras. When held in serum-free medium, untreated OC/CDE 22 cells did not grow at all, while OC/CDE 22 cells transfected with wild-type or mutant N-ras proliferated at a similar rate, which can be explained by the high MAPK activity in these cells. Selective inhibition of the MAPK cascade abolished the growth of OC/CDE 22 cells carrying mutant N-ras in soft agar; furthermore, these cells ceased pile up and formed monolayers on Petri dishes. Thus, activation of the MAPK signaling pathway, though alone not sufficient to malignantly transform liver cells (as shown in liver cells overexpressing wild-type N-ras), is not only essential for growth control but also for the expression of the malignant phenotype (as demonstrated in liver cells transformed by mutated N-ras).

Entities:  

Mesh:

Year:  2000        PMID: 10820486     DOI: 10.1002/(sici)1098-2744(200005)28:1<31::aid-mc5>3.0.co;2-f

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  2 in total

1.  Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse.

Authors:  Corey M Carlson; Joel L Frandsen; Nicole Kirchhof; R Scott McIvor; David A Largaespada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

Review 2.  [Research progress of the resistance mechanism of non-small cell lung cancer to EGFR-TKIs].

Authors:  Huihui Liu; Mengzhao Wang; Ke Hu; Yan Xu; Manjiao Ma; Wei Zhong; Jing Zhao; Longyun Li; Huazhu Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-10-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.